Richard Hall MD, MS

Husband | father to 3 sons | Associate Professor of Medicine @uvadom @uvaCancerCenter | thoracic medical oncologist | Heme/Onc Fellowship Program Director

[Ryan Gentzler, MD @ryangentzler]

Congratulations to our fellow, @DoughertySC91, for his work presented at @IASLC #TTLC25 showing real world outcomes in our cohort treated @UVACancerCenter with mentor @rdhalljr. Many treated outside DeLLphi-301 eligibility criteria, but ORR still 45%. CRS 73%, ICANS 41%.

[Richard Hall MD, MS @rdhalljr]

Honored and grateful for the opportunity to present to the @UVAHealthCareer Board of Visitors meeting about SCLC today. I’m proud to work with @ryangentzler and so many colleagues at @UVACancerCenter

[Ryan Gentzler, MD @ryangentzler]

Thanks to all of the efforts of our team members including pharmacists, inpatient and outpatient nurses, and cancer center leadership who have made implementation of new BiTE therapy, #tarlatamab possible for our small cell lung cancer patients.@rdhalljr @llynchpharmd

[Richard Hall MD, MS @rdhalljr]

Outstanding work by Jenna Schlefman MD presenting on behalf of her co-authors the results of the POWER trial of pre-operative endocrine therapy in early stage breast cancer #ASCO24 @UVACancerCenter #bcsm

[Richard Hall MD, MS @rdhalljr]

Really proud of Shipra Maheshwari MD, 2nd year fellow, presenting on completeness and timeliness of genomic testing in stage 1 - 3 NSCLC at #ASCO24 - congrats to our UVA team and my colleague @ryangentzler!

[Ramy Sedhom, MD, FASCO @ramsedhom]

And a lovely slide on broader implications actions to make high quality telehealth work

[Richard Hall MD, MS @rdhalljr]

@StephenVLiu @ryangentzler @IASLC Outstanding session on EGFR updates during #TTLC24 - proud of @ryangentzler for a very thorough discussion of targeting MET resistance and SCLC transformation

[Ryan Gentzler, MD @ryangentzler]

Congratulations to @UVACancerCenter hem/onc fellow, Phil Young, for his poster at #NACLC23 of multi center study of outcomes for recurrences after stage III #NSCLC treated w chemoRT, immunotherapy. @dwightowenmd @rdhalljr

[Richard Hall MD, MS @rdhalljr]

Really proud of my co-author @MissMeganEl and our #ASCOdailynews article about strategies to improve wellness among fellows https://t.co/oYPbovXilt

[Richard Hall MD, MS @rdhalljr]

Promoting the importance of lung cancer screening with our amazing thoracic team and some really hard to miss lungs today @uvahealthnews

[Richard Hall MD, MS @rdhalljr]

@ramsedhom @jackiebrown_MD @MissMeganEl @KArnaoutakis @marios_tasoulis @laura_huppert @allisongardaMD @rosensteinl Love this group and @ASCO for sponsoring an amazing program

[Richard Hall MD, MS @rdhalljr]

So great to see fellow ESP friends @KArnaoutakis and @rosensteinl at the #ASCO Oncology Training Program retreat today

[Ryan Gentzler, MD @ryangentzler]

Congratulations to Shipra, 2nd yr hem/onc fellow @uvahealthnews @UvaDOM, for presenting her work at the EGFR Resisters Research Summit!

[Ryan Gentzler, MD @ryangentzler]

Eloquent and well-balanced discussion of MARIPOSA and MARIPOSA-2 by @ZPiotrowskaMD. EGFR lung cancer treatment landscape just became much more complicated. Important to incorporate patient perspectives to balance PFS gains with toxicity. #ESMO23

[Richard Hall MD, MS @rdhalljr]

#ESMO23 Outstanding discussion by @ZPiotrowskaMD summarizing MARIPOSA and MARIPOSA2 https://t.co/r3dVhvgP5M highlighting the complexity of caring for our @EGFRResisters patients

[Richard Hall MD, MS @rdhalljr]

#ESMO23 Congrats to @ryangentzler @UVACancerCenter and co-investigators for the MARIPOSA2 study, published in @Annals_Oncology today https://t.co/r3dVhvgP5M

[Richard Hall MD, MS @rdhalljr]

#ESMO23 Thanks Ryan! Congrats to Dr. Aaron Lisberg for an excellent presentation

[Ryan Gentzler, MD @ryangentzler]

Congrats to @rdhalljr for efforts leading TROPION-Lung01 @UVACancerCenter (and welcome to X!). Dato-DXd a potential new treatment option for NS-NSCLC #ESMO23 #lcsm